OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - SYNTA PHARMACEUTICALS CORP ownership

SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 93 filers reported holding SYNTA PHARMACEUTICALS CORP in Q3 2014. The put-call ratio across all filers is 1.91 and the average weighting 1.0%.

Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2015$970,000,000
+96900.0%
500,000
+1900.0%
0.02%
Q4 2014$1,000,000
-75.0%
25,0000.0%0.00%
Q3 2014$4,000,000
-80.0%
25,0000.0%0.00%
Q2 2014$20,000,000
-41.2%
25,0000.0%0.00%
-100.0%
Q1 2014$34,000,00025,0000.00%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q3 2014
NameSharesValueWeighting ↓
CAXTON CORP 37,069,140$64,500,00087.00%
ARMISTICE CAPITAL, LLC 2,000,000$3,480,0001.19%
IRONWOOD INVESTMENT MANAGEMENT LLC 432,259$752,0000.28%
Geller Advisors LLC 187,323$326,0000.21%
CAXTON CORP 57,000$99,0000.13%
Verity Asset Management, Inc. 64,476$112,0000.11%
TFS CAPITAL LLC 367,364$639,0000.06%
Cutler Capital Management, LLC 72,500$126,0000.06%
LUCAS CAPITAL MANAGEMENT 21,100$37,0000.02%
Nine Chapters Capital Management LLC 129,700$226,0000.02%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders